Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


Cell Based Assays

05 Nov 2012 - 06 Nov 2012 - London, UK



Bookmark and Share


SMi’s 5th annual ‘Cell-Based Assays’ conference  will reflect the significant change driving current development in 3D cell culture, Ion Channels as drug targets, Primary Cell Assays and Stem Cells.. Cell-Based Assays is the place for senior scientists from assay development, pharmacology, screening and related fields to meet and discuss progress in the area and exchange ideas moving forward. 

Ion channels are widely regarded as incredibly important therapeutic targets for treating a wide range of pathophysiologies. Our expert speaker line up through day one discusses ion channels and how they can be effectively targeted. Cell-Based Assays 2012 will also focus on 3D cell culture and how recent improvements in this culture method have helped revolutionise and provide physiologically accurate pre-clinical drug research.

Key Reasons to Attend

Explore the latest drug targets and how they are being therapeutically targeted. 

Listen to the latest technologies and processes being utilised in cell based assays, including the most up to date 3D cell culture methods.

Discuss how to best utilise stem cells in preclinical drug research 

Connect with those involved in producing label free assays 

Quote “Technology Network” and save £100

Register online here: http://www.smi-online.co.uk/goto/2012cellbasedassay19.asp



Further information
Scientific News
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!